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ABSTRACT OF THESIS

DETECTION OF ELECTRICAL ALTERNANS IN VENTRICULAR
DEPOLARIZATION PHASE OF HUMAN ELECTROCARDIOGRAM.

T-wave Alternans (TWA) in an electrocardiogram (ECG) has received considerable
interest as a potential predictor of sudden cardiac death (SCD). However, large clinical
trials have shown that while TWA has a very high negative predictive value, its positive
predictive value is poor. Results of previous studies suggest that arrhythmia onset can be
affected by the phase relationship of alternans of the depolarization and repolarization
phase of the action potentials of the ventricles. To assess this relationship, one would first
need to establish that depolarization alternans can be detected and then develop methods
to determine its relationship with repolarization alternans, which is TWA. The objective
of this thesis was to determine whether depolarization phase alternans can be detected in
clinical grade ECGs. To accomplish this, an algorithm was developed to quantify RWave alternans (RWA) in patients who display TWA in their ECGs. Using both the
morphology and amplitude of the R-wave, our results show that RWA can be seen in
clinical ECGs. This suggests that RWA has the potential to help quantify occurrence and
incidence of depolarization alternans, and supports further exploration of the link
between depolarization and repolarization alternans which has the potential to improve
clinical utility of TWA.
KEYWORDS: Depolarization, Repolarization, Alternans, Electrocardiogram, TWA
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Chapter 1 Introduction
Sudden Cardiac Death (SCD) is a condition where unexpected natural death, from
cardiac causes, occurs within a short period of time from the initial onset of symptoms
[1]. It accounts for over 300,000 deaths in the United States each year [2, 3]. With the
onset of death occurring quickly after the first symptom, research has looked for ways to
predict if someone is at risk for SCD. One particular abnormality that has received
attention in the past 30 years, is the detection of T-Wave Alternans (TWA) in an
electrocardiogram (ECG) during a standard stress test [4]. TWA is a result of the action
potential (AP) duration (APD) alternating in length from beat-to-beat during the
repolarization phase. This phenomenon has been linked to electrical instability within in
the heart and can contribute to ventricular arrhythmias.
A recent meta-data study looked at over 2,600 subjects from 19 different studies and
found that even though TWA test has a strong negative predictive value (NPV) (97.2%),
its positive predictive value (PPV) (19.3%) is very weak [5]. This means that if the test is
negative, the patient is unlikely to experience SCD within the next two years. Whereas if
the test is positive, the patient’s certainty of having SCD in the next two years is
unknown. This can result in unnecessary treatment, potentially costing the patient money,
time, and unnecessary anxiety.
One area of study that shows promise in improving the PPV of the TWA test is the
relationship between alternans in the depolarization and repolarization phases of APs. A
study from our laboratory reported in 2012 that when APD alternans was present in
cardiac tissue, alternans in the max rate of repolarization (|dv/dt|max) was also present but
the two were not always in phase [6]. Taking this knowledge and using a canine
ventricular myocyte mathematical model, they investigated the effects of the phase
between APD and |dv/dt|max alternans. In the model, if the two alternans were in-phase,
the alternans of the cells became discordant, which is a phenomenon where short (long)
activation of short-long sequence becomes long (short) as it travels spatially. However, if
they were out-of-phase, no discord occurred. Indicating that when the APD and |dv/dt|max
alternans are out-of-phase, it might have a stabilizing effect and affect discord incidence.
1

In looking for a marker that could be used to identify the presence of |dv/dt|max alternans
in ECG, a dipole field potential spatial model was used (unpublished results by Drs. A.R
Patwardhan and S. Wang). The results of the simulations showed that alternans of
|dv/dt|max resulted in alternans of the R wave amplitude. The purpose of the present thesis
is to determine whether beat-to-beat changes in morphology of the R-Wave are seen in
clinical grade ECGs when TWA is also present. The results of prior studies from our
group suggest that if such changes did occur, inclusion of these in future studies has the
potential to improve the diagnostic value of TWA for SCD.
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Chapter 2 Background
2.1 Cardiac Cycle
The main function of the heart is to pump blood throughout the body. The human heart is
divided into two sides. The right side is responsible for collecting the oxygen-depleted
blood from the body and sending it to the lungs. The left side is responsible for receiving
oxygen rich blood from the lungs and pumping it throughout the body. Each side of the
heart has two chambers, the upper chamber, called the atria, and the lower chamber,
called the ventricle.
The cardiac cycle consists of two stages. First the diastole stage, where the heart is
relaxed and the atria are filling with blood. Next, in the systole stage, the heart contracts
in an organized manner to pump blood from ventricles out of the heart. The sinoatrial
(SA) node located in the upper part of the right atrium controls this cycle. At the start of
the systole stage, an AP is generated by a SA node, and propagated throughout both atria.
This causes the atria to constrict, increasing pressure and pushing blood into the
ventricles. Once the AP reaches the atrioventricular (AV) node, it is delayed shortly
before continuing on to the ventricles. The AV node is a group of pacemaker cells located
between the atrium and ventricles that allows the AP to pass through an otherwise
electrically insulated wall. This short delay gives the atrium enough time to finish
pumping blood into the ventricles and helps to prevent atrial arrhythmias from spreading
to the ventricles. After the short delay, the AP continues down the Bundle of His to the
left and right ventricle through the Purkinje fibers, for a rapid constriction of the
ventricles, pushing blood out of the heart.
2.2 Cardiac Action Potential
A cardiac AP is a brief change in transmembrane potential (TMP) of muscle cells within
the heart. This change is typically caused by the opening and closing of specific ion
channels that cross a cell’s membrane. The cardiac AP consists of 5 phases typically
labeled 0-4, beginning and ending with phase 4.
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Figure 2.1 Cardiac Action Potential. The numbers on the figure 0-4 represent when
each phase occurs in the AP. 0 is for the depolarization phase; 1 is for the early
repolarization phase; 2 is for the plateau phase; 3 is for the repolarization phase; and 4 is
for the resting phase.
Phase 4, referred to as the resting phase, is when the cardiac myocyte’s TMP remains
steady at around -90mV. This potential is controlled by the permeability of the cell
membrane to different ions, with the steady outward leak of K+ having the greatest effect.
When an AP begins, phase 0 starts. Also known as the depolarization phase, phase 0 is
when the TMP rapidly increases. This is typically caused by the adjacent cells electrically
stimulating the cell through gap junctions. This triggers fast-type Na+ channels to open,
causing a rapid influx of positive Na+ ions, with the TMP peaking around +25mV. Next
in phase 1, referred to as early repolarization phase, is when the Na+ channels deactivate
and the transient K+ channels open allowing K+ ions to leave the cell which brings the
TMP back near 0mV. Then phase 2, described as the plateau phase, starts. Here is when
Ca2+ enters the cell through long-type Ca2+ channels, which electrically balances out the
efflux of K+ ions. This causes a plateau to form. Phase 3, known as the repolarization
phase, is when more Ca2+ channels close and the steady outward flow of K+ slowly
lowers the potential back to resting potential.
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2.3 Electrocardiogram
An ECG is a surface measurement of the electrical activity of the heart. It is often used to
detect cardiac abnormalities such as arrhythmias, myocardial infarction, and electrolyte
imbalances. With each phase of the cardiac cycle, the electrical signals within the heart
affect the electrical signal on the surface of the body. The three main events of each
heartbeat correspond to the three main features of the ECG. The P-wave corresponds to
atrial depolarization, the QRS complex corresponds to the ventricular depolarization, and
the T-Wave corresponds to ventricular repolarization.
2.4 Repolarization Alternans
Repolarization alternans is defined as the beat-to-beat variation in APD and has been
linked to ventricular fibrillation [7-9]. This phenomenon can be detected in an ECG as
alternans in the morphology and/or amplitude of the T-Wave [10, 11].
2.5 Depolarization Alternans
Alternans are not only found in the repolarization phase of APs, but are also found in the
depolarization phase [12, 13]. A study published in our laboratory in 2012 looked at the
relationship between APD alternans and |dv/dt|max alternans [6]. They found that when
APD alternans were detected, |dv/dt|max alternans were also always detected. Most of the
time (96%-Swine, 74%-Canine) these two were in-phase with each other. However, some
of the time they were not. They concluded that these two alternans can become
independent of each other. The following figure shows the possible relationships between
APD and |dv/dt|max alternans.
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In-Phase

Out-Of-Phase

Figure 2.2 APD and |dv/dt|max In-Phase and Out-of-Phase relationship. Both APD
(A, D) and |dv/dt|max (B, E) traces display beat-to-beat alternating patterns. (C, F) Show
overlays of APD alternans (open circle) and alternans of |dv/dt|max (closed diamonds).
(Reproduced with permission from [6])
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2.6 Discordant Alternans
Spatial discord of alternans is a phenomenon where short (long) activation of the shortlong sequence becomes long (short) as it travels spatially and has been linked to the onset
of arrhythmia [14]. This discord can be affected by the phase between APD and |dv/dt|max
alternans. One study used a canine ventricular myocyte model to show that by only
changing the phase relationship between APD and |dv/dt|max alternans, discordance
presence was affected [6]. When the two alternans were in-phase with each other,
discordances among the cell occurred. However, when only the phase changed,
discordance did not occur. This indicated that the phase might affect the occurrence of
discordance.
Out-of-Phase

In-Phase

B

Cell

Cell

A

Time

Time

Figure 2.3 APD and |dv/dt|max In-Phase and Out-of-Phase Time-Space Plots. TimeSpace plots of simulated Out-of-Phase (A) and In-Phase (B) relationship between
depolarization and repolarization alternans. (Reproduced with permission from [6])

2.7 Alternans in ECG
Since it is not possible to measure |dv/dt|max from the ECG, a dipole field potential spatial
model (described in the next section) created by Dr. Siqi Wang may provide a way to
detect the effects of |dv/dt|max alternans from surface ECGs. To test this idea, a simulation
was conducted using the model where every element in the model had the same |dv/dt|max
alternans. The difference in |dv/dt|max between the beats showed up in the amplitude of
the R-wave. The fallowing figure shows the difference between two beats with |dv/dt|max
alternans in red at the peaks of the R-Wave.
7

Figure 2.4 12 Lead ECG Model Showing Depolarization Alternans. Each tracing
contains two beats from an ECG signal generated from AP with depolarization alternans.
The red shows the difference between the two beats (Results provided by Dr. Siqi Wang).

2.8 Dipole Field Potential Spatial Model.
The dipole field potentials spatial model was used to look at the effects that different AP
can cause on a standard surface ECG. This model was made up of 129,826 time-varying
current dipole elements in the shape of a cone comparable in size to adult’s ventricles.
Each element had electrical properties that matched clinical and experimental data. For
the torso, a homogenous volume conductor was used which matched the conduction
properties and size of an adult human torso. The simulated ECG electrodes were
positioned approximately the same distance and position of a traditional ECG’s
electrodes. Using the standard clinical lead locations, RA, LA, LL, V1, V2, V3, V4, and
V5 were the lead locations used to compute ECGs.
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Figure 2.5 Dipole Field Potential Spatial Model. This figure shows a 3D view (A),
front view (B) top view (C) and side view (D) of the model. The red dot represents the
location of the different leads that would typically be used in an ECG. (Results provided
by Dr. Siqi Wang).
In order to calculate the potential at the location for each ECG lead, first the model had to
calculate the electrical field around each element. This was done by combining the
intracellular potential, extracellular potential, and net membrane current per unit volume
for each dipole element. Then integrating all those elements by knowing distance and
direction for each ECG electrode, the body surface potential could be calculated.
To save computing time, the action potentials were generated and saved in look up tables
that each element could pull from.

The following figure compares a recorded

intracellular AP and the modeled intracellular AP.
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A

B

Figure 2.6 Actual AP vs Model AP. Shows a recorded intracellular human AP from our
lab (A) vs a model Intracellular AP (B) (Results provided by Dr. Siqi Wang).
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Chapter 3 Methods
For this study, 2 programs were created in MATLAB to detect alternans. The first
program was used to detect TWA in the ECG. The second program looked at only the
ECGs in which TWA were detected and analyzed RWA of the morphology and
amplitude of the wave. Both programs used the same preprocessing and data reduction
steps. Below is a flow chart of the process.
Alternans Detection Flow Chart
ECG
T-Wave
Alternans
Detection
Program

Preprocessing
(3.1)
Data Reduction
(3.2)
Morphology Alternans
Detection (3.3)

No

TWA
Detected?

Reject

Yes
R-Wave
Alternans
Analysis
Program

Preprocessing
(3.1)
Data Reduction
(3.2)

Morphology Alternans
Detection (3.3)

Amplitude Alternans
Detection (3.4)

Figure 3.1 Alternans Detection Flow Chart.
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3.1 Preprocessing
The first step of the preprocessing stage was to extract the ECG signal and sampling rate
from the containing file. Then a zero-phase band pass digital filter was applied to the
signal to remove excess noise. The filter was a second order Butterworth filter with cut
off frequencies at 0.01 Hz and 60 Hz.
After the signal was filtered, each R-Wave peak was detected using the algorithm laid out
by Pan and Tomkins QRS detection algorithm [15]. To accomplish this, the program first
normalized the filtered ECG. For each sample in the signal, the signal’s mean was
subtracted and then divided by the signal’s absolute max. A second order bandpass filter
was then applied to the normalized signal with cut off frequencies of 5 Hz and 12 Hz. A
five-point derivative then differentiated the filtered signal and each sample was then
squared. Next, the signal was integrated by using a moving square window of 150ms,
which is the approximate width of a QRS complex. Each R-wave peak was then located
using the signal’s mean as a threshold and minimum of 200ms between each peak.
After each R-wave peak had been located, fiducial points for each beat were located
using the methods laid out by Weiss et. al. [11]. First, the T-wave preliminary boundaries
were located by using the R-to-R (RR) interval between the current and previous R-wave
peaks. If the RR interval was greater than 770ms, the T-wave was considered to start at
100ms after the R-peak. If the RR interval was between 770ms and 320ms, the T-wave
was considered to start 40ms plus 7.8% of the RR interval and the R-peak. If the RR
interval was less than 320ms, the T-wave was considered to start 65ms after the R-peak.
The T-wave was considered to end 500ms after the R-peak if the RR interval was greater
than 77ms or 65% of the interval after the R-peak if the RR interval was less than 77ms.
The preliminary QRS complex start boundary was considered to start 50ms before the Rwave peak. The preliminary QRS complex end boundary was considered to end by either
80ms after the R-wave peak or the T-wave start boundary, whichever one was shortest.
Then the final boundaries were located by first removing the linear baseline from each
wave’s window, by subtracting the window’s mean from each sample. After squaring
each sample, the cumulative summation of each sample was found. The final wave
boundaries were located at 1% and 99% of the summation.
12

After the fiducial points were located, the baseline wander was removed from the
original filtered signals. This was done by using a cubic spline interpolation. The control
points used for this interpolation were the QRS start boundary for each beat.
3.2 Data Reduction
In the data reduction section, all abnormal beats were detected and labeled using both the
RR interval and R-wave correlation laid out by Weiss et. al. [11]. If either method
flagged a beat as abnormal, then it was considered abnormal.
The RR interval method flagged abnormal beats by taking the previous RR interval and
comparing it to the mean of the preceding 7 RR intervals. If the previous RR interval was
less than 90% of the mean, then the current, next, and previous beats were labeled
abnormal.
The R-wave correlation method compared the current beat’s R-wave to a median R-wave
template generated from 127 beats. This was done by first normalizing each R-wave used
in the template and the current R-wave. A 80ms window centered at each R-wave peak
was used as the window for the wave. Then the mean of the isoelectric segment, defined
as 10ms before the start of each QRS complex, was subtracted from each sample to
normalize each R-wave window. Then a median R-wave template was generated from
the 127 normalized beats. Next, the current R-wave’s window and the median R-wave’s
template were cross-correlated twice to insure proper alignment. After that, the
correlation coefficient was calculated between the beats. If the coefficient was less than
95%, then the tested beat was considered abnormal.
3.3 Morphology Alternans Detection
To quantify alternans in the morphology of an ECG, the spectral method laid out by
Weiss et al was used [11]. This was done on a beat-by-beat basis by analyzing 128 beat
sequence, then shifting the sequence one beat to the right. This was repeated until all the
beats in the ECG were part of a sequence.
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First, the beat sequence was tested to see if it was indeterminate. To do this, the number
of normal beats was compared to the total number of beats. If there are less than 90%
normal beats within the sequence, then that sequence was labeled indeterminate.
The next step was to generate a cumulative power spectrum of the 128 beats in the
sequence. This was done by first generating an even and an odd median template from
the normal beats. Next, an array was created from all the beats. The rows contained the
beats and the columns were the samples. If the beat was abnormal, a corresponding even
or odd template replaced the row. Then, a Fast Fourier Transform (FFT) was calculated
on each column and the rows were summed up to generate a cumulative power spectrum.

Power/Frequency (dB/cycle/beat)

Cumulative Power Spectrum

Frequency (cycle/beat)
Noise Alternans
Figure 3.2 Cumulative Power Spectrum. Alternans occur at the 0.5 cycle/beat and
noise was between 0.43 and 0.46 cycles/beat. (Signal from Physionet.org [16])
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This cumulative power spectrum was used to determine if the series of beats contained
alternans. The following equations were used.
𝑎𝑙𝑡𝑒𝑟𝑛𝑎𝑛𝑠 𝑣𝑜𝑙𝑡𝑎𝑔𝑒 (µ𝑉) = √𝑎𝑙𝑡𝑒𝑟𝑛𝑎𝑛𝑠 𝑝𝑒𝑎𝑘 − µ𝑛𝑜𝑖𝑠𝑒
Equation 3.1 Alternans Voltage Equation. The 𝑎𝑙𝑡𝑒𝑟𝑛𝑎𝑛𝑠 𝑝𝑒𝑎𝑘 was located at 0.5
cycle/beat and µ𝑛𝑜𝑖𝑠𝑒 is the mean of the noise window between 0.43 and 0.46 of the
aggregated power spectrum.
𝐾𝑠𝑐𝑜𝑟𝑒 = (𝑎𝑙𝑡𝑒𝑟𝑛𝑎𝑛𝑠 𝑝𝑒𝑎𝑘 − µ𝑛𝑜𝑖𝑠𝑒 )/𝜎𝑛𝑜𝑖𝑠𝑒
Equation 3.2 Alternans Kscore Equation. The 𝑎𝑙𝑡𝑒𝑟𝑛𝑎𝑛𝑠 𝑝𝑒𝑎𝑘 was located at 0.5
cycle/beat and µ𝑛𝑜𝑖𝑠𝑒 is the mean and 𝜎𝑛𝑜𝑖𝑠𝑒 was the standard deviation of the noise
window between 0.43 and 0.46 of the aggregated power spectrum.
The alternans voltage equation directly measures the magnitude of alternans within the
series. The Kscore was the statistical significance of the alternans voltage. To determine if
alternans were present, the following criteria needed to be met: (1) alternans voltage >
1.0 µ𝑉 and Kscore > 3 [11].
The fiducial points located in the preprocessing defined the window for each wave. For
the T-wave, the window was from the end of the QRS complex to the end of the T-wave.
For the R-wave, the window was 80ms centered at the peak of the R-wave.
3.4 R wave Amplitude Alternans Detection
In this study, to classify a series of beats as containing R wave amplitude alternans, three
criteria needed to be met. First, the peak height needed to alternate from beat to beat (i.e.
tall-short-tall or short-tall-short) for 5 times or more, i.e. five sequential alternating
changes in height. Second, the absolute difference between each beat’s amplitude and the
previous must be greater than 5% of the mean of all the R-wave peak heights in the
signal. Third, none of the beats in the series were labeled abnormal.
3.5 Validation of TWA computation
To ensure the TWA detection program was working properly, the program was validated
using the challenge data and results from PhysioNet’s 2008 T-Wave Alternans Challenge
[17]. This challenge asked participants to create an automated system that could rank 100
two minute segments of ECG signals by the magnitude of T-Wave alternans from 1 to
15

100. Their rankings would then be compared to a reference ranking and scored. There
were 56 human ECGs obtained from individuals at risk for SCD, 12 from healthy
subjects and 6 from a normal sinus rhythm database. The other 32 ECGs were synthetic
with known TWA magnitude. The reference ranking was determined from the median
participant’s rankings who could successfully distinguish between the high and low
synthetic ECGs. Because PhysioNet’s challenge was over before the study started, we
could compare the final reference ranking to our program’s ranking. The following chart
shows the reference ranking vs the program’s ranking.
TWA detection Program Ranking VS PhysioNet Ranking

TWA Detection Program Ranking

Patient

Syn

100
90
80
70
60

50
40
30
20
10
0
0

10

20

30

40

50

60

70

80

90

100

PhysioNet 2008 Challenge Reference Ranking

Figure 3.3 Graph PhysioNet challenge rankings vs the programs rankings. The Xaxis is the reference ranking of each file in the challenge with 1 being the least TWA
detected, and 100 being the most detected. The Y-axis is how our program ranked the
files, with 1 being the least TWA detected and 100 being the most. The blue dots are
synthetically generated ECG samples that have known TWA magnitudes. The Green dots
are samples from various human ECG’s in the PhysioNet Library.
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3.6 Statistical analysis of sequential changes in heights of R wave
For this part of the study, the purpose was to determine the probability that a series of
sign changes could have happened by chance. We chose an empirical method to
determine the probability. To do this we first generated a sequence of 10,000 random
binary numbers with equal probability of being 1 or 0. We then looked for how many
times there were 5 number changes (i.e. 101010 or 010101). Then we calculated the
probability by taking that number and dividing it by the number of samples tested. After
repeating this 10,000 times and taking the average probability, we obtained that the
probability that a sequence of 5 changes could occur is 3.1%, i.e. comparable to a P-value
< 0.05.
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Chapter 4 Data and Results
4.1 Data Source
The data used in this study came from 9 different databases on PhysioNet.org [16].
PhysioNet’s website contains a large number of recorded human physiological signals
that are freely available to the public under the ODC Public Domain Dedication and
License v1.0 to be used for research. The National Institute of General Medical Science
(NIGMS) and the National Institute of Biomedical Imaging and Bioengineering (NIBIB)
supports this website. A description of each database used is in the following paragraphs.
The European ST-T database (EDB) was assembled from subjects who were diagnosed
or suspected to have myocardial ischemia and had ST and T-wave changes [16, 18].
There were 90 ECG recordings from 79 different subjects, each 2 hours long. Each
recording was sampled at 250 Hz with 12-bit resolution over a 20mV input range.
The Long-Term AF Database (LTAFDB) was assembled from subjects with paroxysmal
or sustained atrial fibrillation [16, 19]. There were 84 long-term ECG recordings with
lengths ranging from 24 to 25 hours. Each recording was sampled at 128 Hz with 12-bit
resolution over 20 mV range.
The MIT-BIH Long Term Database (LTDB) contains 7 long-term ECG recordings from
14 to 22 hours [16]. Each record sampled at 250 Hz with 12-bit resolution over a 20mV
range.
The Long-Term ST Database (LTSTDB) was assembled from subjects that exhibit a
variety of events in the ST segment portion [16, 20]. These include ischemic ST episodes,
axis-related non-ischemic ST episodes, episodes of slow ST level drive, or a mixture of
all 3. There were 86 ECG recordings from 80 subjects each ranging from 21 to 24 hours
long. Each record was sampled at 250 Hz with 12-bit resolution of a ±10 mV range.
The MIT-BIT arrhythmia database (MITDB) was comprised of ECG recordings that
were used in the study of cardiac arrhythmias [16, 21]. There were 48 ECG recordings
from 47 subjects each having a length of 30 minutes. Each recording was digitized at 360
Hz with 11-bit resolution over a 10mV range.
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The Sudden Cardiac Death Holter Database (SDDB) was made up from complete holster
recordings from patients that had a sustained ventricular tachyarrhythmia with most
having had actual cardiac arrest [16, 22]. There are 23 complete holter recordings, which
include 18 subjects with underlying sinus rhythm, 1 who was continuously paced, and 4
with atrial fibrillation. All patients had a sustained ventricular tachyarrhythmia, while
most had experienced cardiac arrest. Each recording was recorded at 250 Hz with 12-bit
resolution over a 20mV range.
The MIT-BIH ST Change Database (STDB) contained ECGs recordings that
exhibit ST segment abnormalities [16, 23]. There are 28 recordings, with 23 of them
recorded during an exercise stress test and showed transient ST depression. The other 5
recordings were excerpts from long-term ECG recordings that exhibit ST elevation. Each
recording was sampled at 360 Hz with 12-bit resolution over 20mV range.
The St.-Petersburg Institute of Cardiological Technics 12-lead arrhythmia
database (INCARDTDB) contained ECGs from patients being tested for coronary artery
disease [16]. It was comprised of 75 half-hour recordings from 32 holter recordings.
None of the patients had pacemakers, while most of them had ventricular ectopic beats
and displayed signs of ischemia, coronary artery disease, conduction abnormalities and
arrhythmias. Each recording was sampled at 257 Hz with gains varying from 250 to 1100
analog-to-digital converter units per millivolt.
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4.2 Alternans Detection
This study analyzed 441 ECGs that came from 8 different databases from PhysioNet.org.
Of those 441 ECG, TWA was detected in 318 of them. Of the 318 files that TWA was
detected, morphological RWA was detected in 309 and amplitude RWA was detected in
287.
Table 4.1 Number of Files in which Alternans Were Detected. This table shows how
many files from each database were analyzed and TWA was detected. It also shows the
percentage of files that RWA morphological and amplitude alternans were detected from
the files TWA were detected.
Database
Total # of
# of ECG that % of TWA
% of TWA
ECG
TWA was
ECG that
ECG that
Detected
Morphological Amplitude
RWA was
RWA was
Detected
Detected
90
84
100%
90.4%
edb
84
41
100%
100%
ltafdb
7
6
83.3%
83.3%
ltdb
86
65
100%
100%
ltstdb
48
33
90.9%
72.7%
mitdb
23
21
100%
100%
sddb
28
23
95.7%
78.3%
stdb
75
45
91.1%
82.2%
incartdb
All ECG’s
441
318
97.2%
90.3%
4.3 Morphological RWA
After TWA was detected in each ECG, the next step was to look for alternans in the
morphology of the R-wave. The program looks at 128 beat sequences and flags them
positive if alternans was found or negative if not, based on the description in chapter 3.
Then the number of positive sequences was divided by the number of positive and
negative sequences to find the percentage of positive morphological RWA sequences
within in the ECG. The table below shows the average and standard deviation of the
percentages of positive sequences from all the files in each database. In addition, it shows
the percentage from the ECG that had the highest positive percentage within that
database.
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Table 4.2 Morphological RWA. The percentage of positive morphological RWA was
calculated by finding the percentage of positively flagged alternans sequences of the total
of all positive and negative flagged alternans sequences.
Database
% of Positive
% of Positive
Morphology
Morphology
RWA (Avg±Std)
RWA (Max)
edb
ltafdb
ltdb
ltstdb
mitdb
sddb
stdb
incartdb
All ECG’s

3.20% ± 1.90%
6.36% ± 3.08%
8.76% ± 1.84%
3.28% ± 1.40%
5.93% ± 9.08%
4.19% ± 2.20%
3.71% ± 4.54%
6.12% ± 7.52%
4.48% ± 4.65%

12.90%
18.79%
10.94%
9.16%
46.32%
9.72%
20.36%
44.23%
46.32%

4.3 Amplitude RWA
The second part of this project was to look for amplitude RWA. Here we looked for a
series of 6 normal beats or more, the height of these beats to alternate and if the absolute
change from peak to peak was greater than 5% of the mean of all the peaks. Table 4.3
shows the average, standard deviation, and max percentage of beats that are part of one of
these sequences for each database. Table 4.4 shows the duration of each sequence.
Table 4.3 Amplitude RWA Number of
RWA sequence.
Database
% of Beats part of
an amplitude
RWA sequence
(Avg±Std)
3.23% ± 3.25%
edb
2.31% ± 2.58%
ltafdb
1.73% ± 1.88%
ltdb
3.32% ± 3.28%
ltstdb
5.76% ± 7.83%
mitdb
3.98% ± 5.11%
sddb
2.96% ± 2.26%
stdb
2.75% ± 2.38%
incartdb
All ECG’s
3.28% ± 3.84%

Beats. Percentage of beats that are part of a
% of Beats part of
an amplitude
RWA sequence
(Max)
13.33%
10.77%
4.79%
10.14%
38.27%
19.08%
9.15%
10.02%
38.27%
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Table 4.4 Amplitude RWA Durations. The duration was how many sign changes occur
in a sequence.
Database
Mean
Median
Max
Number of
Duration
Duration
Duration
Durations
Length
Length
Length (Max)
(Avg±Std)
(Avg±Std)
(Avg±Std)
5.69 ± 0.39
5.37 ± 0.54
20
edb
39.08 ± 42.99
5.66 ± 0.29
5.21 ± 0.41
25
ltafdb
228.63 ± 296.09
5.46 ± 0.31
5.14 ± 0.35
14
ltdb
128.40 ± 118.49
5.83 ± 0.60
5.36 ± 0.53
133
ltstdb
492.74 ± 509.48
5.74 ± 0.62
5.44 ± 0.52
15
mitdb
15.54 ± 19.83
5.95 ± 0.54
5.37 ± 0.65
32
sddb
221.57 ± 236.59
5.82 ± 0.51
5.36 ± 0.52
21
stdb
11.00 ± 8.56
5.78 ± 0.93
5.34 ± 0.53
19
incartdb
7.59 ± 7.32
All ECG’s
5.76 ± 0.56
5.33 ± 0.52
133
176.02 ± 333.02
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Chapter 5 Discussion
Researchers have studied TWA as a predictor for SCD [1, 4]. With its very strong
negative predictive value, it is a very appealing test that could potentially weed out
patients who are not at risk for SCD. However, with its weak PPV, it can cause people
who are falsely flagged for SCD to waste time and money on treatment that they do not
need. The overall goal of our laboratory is to investigate potentially complementary tests
in order to improve the PPV of the TWA test. One potential feature of electrical function
that has shown promise in recent years was alternans in the depolarization phase of APs
and its relationship with alternans of APD.
Using mathematical models and tissue level microelectrode recordings, the relationship
between |dv/dt|max alternans and APD alternans affects if discordant alternans can occur
in tissue [12, 24]. Until now, |dv/dt|max alternans have only been detected using
microelectrodes. However, using a dipole field potential spatial model, the effect of
|dv/dt|max alternans may be detectible in the R-wave of ECGs.
The purpose of this study was to determine if alternans of the R-wave amplitude and
morphology are detectable in clinical grade ECGs.
5.1 TWA Detection Program
For this project, the purpose was to determine if RWA occurs in ECGs that already have
TWA. We decided to use the spectral method to detect TWA because it was well
established as a detector of TWA [11].
To verify that our TWA detection program was accurate, we used the 2008 PhysioNet’s
TWA challenge as our testing standard. We had our program rank the dataset provided in
the challenge and compared our results to its final rankings. Figure 3.4 shows that even
through our program did not detect TWA in every ECG from the PhysioNet’s challenge,
the ECGs that it did detect, were among the highest rankings. Also, the program validated
well with synthetic ECGs (with known TWA) than the clinical ECGs with unknown
TWA. This indicates that our program had a conservative, but accurate approach when
detecting TWA.
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The program was conservative because each ECG from the PhyioNet’s challenge was 2
minutes long. Our program looked at sequences that are 128 beats long, which was often
longer than half the total ECG length. If the signal was noisy and not enough beats were
normal in the ECG, all of the sequences were labeled indeterminate. This would cause the
program to say there was no TWA present in the ECG. Because the objective at this stage
was not looking at the frequency of occurrence of RWA, but looking for its presence, the
conservative nature of the program was not a major concern.
5.2 Morphological RWA
For this study, we used a method similar to that used for TWA detection to determine if
alternans in the morphology of the R-wave does occur. When looking for morphological
RWA, we used the same logic used to locate TWA, because this method was already
shown to detect alternans of the T wave.
Table 4.1 shows that of the 318 files in which TWA was detected, 309 of those files
contained morphological RWA. We can also see that within the ECG, morphological
RWA was present on average in 5% of the signal (table 4.2), although it can reach as
high as 46%. This indicates that not only does morphological RWA occur in ECGs when
TWA was detected, it could be a common occurrence. Further research is required to
better estimate the frequency of occurrence of this phenomenon.
5.3 Amplitude RWA
The dipole field potentials spatial model that Dr. Siqi Wang developed showed that
|dv/dt|max alternans appeared as alternans in the amplitude of the R-wave. For this study,
we wanted to see if the amplitude of the R-wave had alternans when TWA was present.
We discovered that the average percentage of beats that were part of an amplitude RWA
sequence was 3.2%. We also saw this percentage to be as high as 38.27%. These results
supports the possibility of using RWA as a means to look at the relationship between
depolarization alternans and TWA.

24

In table 4.4, we see that the average length of the amplitude RWA duration was around
5.7, which was just slightly larger than the minimum length for a sequence. But we did
see duration lengths as long as 133 beats. This leads us to conclude that we can
potentially use the relationship between amplitude RWA and TWA, to look at the
relationship of the depolarization and repolarization phase of AP alternans.
5.3 Conclusion
In Conclusion, this study determined that in clinical grade ECGs, where TWA can be
detected, RWA was detectable. This observation supports further exploration of whether
the RWA has the potential be used as a complementary test to TWA for prediction of
SCD. This use has the potential to improve the PPV of the TWA. Improving the PPV
value will greatly reduce unnecessary treatment and excessive spending for SCD.
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